Phase Holographic Imaging’s closest competitor acquired for $320 million
Recently it was announced that Sartorius acquires Essen BioScience for $320 million in cash. Like Phase Holographic Imaging’s main product HoloMonitor®, Essen BioScience main product IncuCyte is a cell analyzer designed to be placed in a cell incubator to study the behavior of living cells over long time periods. Contrary to HoloMonitor, IncuCyte is based on conventional microscopy which in most cases requires that the cells are genetically modified or stained with toxic stains. For more information about the acquisition see Sartorius to Acquire Real-Time Live-Cell Analysis Pioneer and